Skip to main content

Cost-effective reimbursement analysis for medical technologies in Europe

Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 34 EU countries

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Transcatheter intracardiac pacing systems added to the List of reimbursable devices in Belgium

In March 2023, the National Institute for Health and Disability Insurance (INAMI-RIZIV) updated the List of reimbursable devices and Nominative lists to take effect on April 1, 2023.

Eight new codes for intracardiac transcatheter pacing systems with the corresponding conditions of reimbursement were added to the List of reimbursable devices. Some examples of new codes are provided below:

  • 182851-182862 First implantable intracardiac transcatheter pacemaker for right ventricular pacing and sensing, including placement system;
  • 182873-182884 Replacement of implantable intracardiac transcatheter pacemaker for right ventricular pacing and sensing, including placement system;
  • 182932-182943 First implantable intracardiac transcatheter pacemaker for right ventricular pacing, as well as atrial sensing, including placement system;

Certain branded devices must be registered on the Nominative list in connection with the new codes to be reimbursed. Micra VR and Micra AV (by Medtronic) were added to the Nominative list.

See more information in French here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.